Stock Markets March 24, 2026

BofA Returns to Buy on Oracle, Citing AI Cloud Demand and Massive Backlog

Bank sets $200 target as investors weigh long-duration contracts, capital intensity and customer concentration

By Sofia Navarro ORCL
BofA Returns to Buy on Oracle, Citing AI Cloud Demand and Massive Backlog
ORCL

Bank of America has reinstated coverage of Oracle at Buy with a $200 price target, driven by accelerating demand for AI infrastructure and cloud services and a $553 billion backlog of long-term performance obligations. The bank highlights timing of revenue conversion, customer concentration and heavy capital spending as the central uncertainties while forecasting strong revenue growth amid margin pressure.

Key Points

  • BofA reinstated Oracle at Buy with a $200 price target - implying roughly 30% upside.
  • Oracle’s remaining performance obligations total $553 billion, offering visibility into long-term cloud and AI commitments.
  • Analysts forecast revenue growth of 17%, 33% and 46% for FY26-FY28 as OCI capacity expands, but expect roughly 1,200 basis points of gross margin compression.

Bank of America has reinstated coverage of Oracle at a Buy rating with a $200 price objective, a target the bank says implies roughly 30% upside from current levels. The move rests on what analysts describe as mounting demand for AI-focused infrastructure and cloud capacity, underpinned by a substantial backlog of long-duration commitments.

Investment case and analyst view

Analysts at the bank, including Tal Liani, characterized Oracle as "a giant going all-in on AI infrastructure and the cloud." The reinstatement to Buy, the team said, reflects a calibrated view that balances accelerating AI infrastructure demand against the practicalities of timing, customer concentration and the capital demands of a major strategic transformation.

Backlog gives revenue visibility - but with caveats

A central pillar of BofA's thesis is Oracle's remaining performance obligations (RPO), which the bank values at $553 billion. That backlog is tied largely to long-duration AI training and cloud infrastructure commitments and, according to the analysts, "provides solid visibility for a meaningful growth opportunity." They caution, however, that execution will be crucial as Oracle scales capacity and converts contracts into revenue.

On timing, the bank noted that more than 57% of the RPO is scheduled beyond three years and around 22% beyond five years. This timing profile heightens reliance on data-center readiness, GPU deliveries and partner execution as prerequisites for converting obligations into recognized revenue.

Customer concentration

BofA flagged customer concentration as another material consideration. A significant portion of the backlog is linked to a small group of AI developers, with OpenAI explicitly noted among those customers. Concentration increases the importance of retaining and executing on relationships with a limited set of large buyers.

Capital intensity and cash-flow outlook

The analysts emphasized the capital-intensive nature of Oracle's shift toward hyperscale data-center capacity. BofA projects that Oracle's capital expenditures will reach about $50 billion in fiscal 2026 (FY26) and continue rising through FY29. Over that period, free cash flow is expected to remain negative, implying ongoing need for access to external financing.

"However, front-loaded investments are typical during disruptive innovation cycles and we therefore focus on performance beyond the investment cycle," the analysts added, highlighting that the near-term cash profile must be weighed against potential longer-term returns once the investment phase matures.

Financial forecasts and margin implications

BofA's financial outlook incorporates aggresssive capacity expansion for Oracle Cloud Infrastructure (OCI). The bank forecasts revenue growth of 17%, 33% and 46% in FY26, FY27 and FY28, respectively, as OCI capacity scales. At the same time, BofA anticipates roughly 1,200 basis points of gross margin compression during the same window, reflecting the cost of building and provisioning the additional infrastructure.

Balancing upside and execution risk

While the analyst team acknowledges material execution and financing risks, they also note that the market has partly priced in downside following a sharp pullback in Oracle's stock from its 2025 peak. The $200 target represents BofA's view of risk-reward given the company's sizable backlog, expected revenue trajectory and the near-term capital demands of scaling infrastructure.

Third-party evaluation mention

Separately, the article included a note that an AI-driven screening tool evaluates Oracle alongside thousands of other companies each month using over 100 financial metrics to generate stock ideas and assess fundamentals, momentum and valuation.

Bottom line

BofA's reinstatement of Buy on Oracle hinges on a large RPO tied to long-term AI and cloud commitments, substantial projected revenue growth as capacity expands, and heavy, front-loaded capital spending that will pressure free cash flow in the near term. The outlook is therefore a balance between a significant growth opportunity and measurable execution and financing risks.

Risks

  • Timing risk - More than 57% of RPO is scheduled beyond three years and around 22% beyond five years, increasing reliance on data-center readiness, GPU deliveries and partner execution.
  • Customer concentration - A significant share of backlog is tied to a small number of AI developers, including OpenAI, amplifying counterparty and retention risk.
  • Capital and cash-flow risk - BofA expects capex of about $50 billion in FY26 with rising investment through FY29 and free cash flow projected to remain negative, requiring continued access to external financing.

More from Stock Markets

Zoox Schedules Robotaxi Pilots in Austin and Miami as U.S. Rollout Expands Mar 24, 2026 BoE Signals Readiness to Counter Inflationary Effects from Middle East Developments, Pill Says Mar 24, 2026 QatarEnergy invokes force majeure after missile strikes damage Ras Laffan facilities Mar 24, 2026 Jefferies trims European software price targets as AI optimism wanes and geopolitics bite Mar 24, 2026 ImmunityBio Shares Drop After FDA Warns Over Misleading ANKTIVA Promotions Mar 24, 2026